UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jun 30, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jun 29, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$544.92
Jun 29, 2026
Close before public filing
$544.92
Jun 29, 2026
Return since public filing
-8.29%
Through Aug 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000088
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.47M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jun 29, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $64.8K |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $194.85K |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $43.35K |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $317.87K |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $867.78K |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $1.18M |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $931.4K |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $415.26K |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $933.19K |
| United Therapeutics Corp UTHR | Sale | Jun 29, 2026 | $236.05K |
| United Therapeutics Corp UTHR Current | Exercise | Jun 29, 2026 | $0 |